Quality assessment was conducted on all included studies at the full-text review stage, using a modification of the method outlined in Eubank et al.
#Kanso 2 headband series#
Key exclusions were: studies with sample sizes smaller than 20 case studies, case series and narrative reviews studies published before 2005 (so that only studies on new-generation technology were included) pediatric populations studies of hearing preservation bilateral CIs electroacoustic stimulation or hybrid hearing and single-sided deafness with tinnitus suppression.ĭata Extraction and Statement Developmentĭata relevant to the six key areas of interest were extracted manually from the included studies, and consensus statements were drafted based on the findings. Full-text versions of all publications meeting the eligibility criteria at initial screening were reviewed to confirm eligibility. SRs of observational studies, prospective and retrospective studies, and cross-sectional and longitudinal studies were included. The searches were limited to human studies published in English language and conducted in Australia, Canada, China, Europe, India, Japan, the UK, and the USA.
The title and abstract of the identified publications were screened manually against prespecified eligibility criteria. i) MEDLINE In-Process & Other Non-Indexed Citations and OVID MEDLINE, 1946–present ii) Embase, 1974–present and iii) Cochrane Library, comprising Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, Cochrane Central Register of Controlled Trials, National Health Service Economic Evaluation Database, the Health Technology Assessment database, and the American College of Physicians Journal Club. The literature searches were conducted on July 18, 2018, in the following electronic databases. This resulted in 20 evidence-based statements that are in line with real-world clinical experience.Ī Systematic Review was performed to identify studies relevant to at least one of the following six key areas: i) level of awareness of CIs ii) best practice clinical pathway from diagnosis to surgery iii) best practice guidelines for surgery iv) best practice guidelines for rehabilitation v) factors that affect CI performance and outcomes and vi) cost implications of CIs. How did they do it?Ī Delphi consensus panel of 30 international specialists voted on statements about cochlear implant use, informed by a systematic review of the literature and clinical expertise. They could inform the development of clinical practice guidelines, which could increase access to cochlear implants worldwide and improve hearing and quality of life in eligible adults. The consensus statements provide recommendations on the use of unilateral cochlear implants in adults with bilateral severe, profound or moderate sloping to profound sensorineural hearing loss. What was the goal of the consensus paper?Ĭonsensus statements were developed regarding the use of unilateral cochlear implants in adults with severe, profound or moderate sloping to profound bilateral sensorineural hearing loss. The aim of this paper is to describe the findings of the Delphi consensus study on cochlear implant use in adults and to present the resulting consensus statements agreed by the Delphi panel.ĭELPHI GROUP: Craig A Buchman MD, René H Gifford PhD, David Haynes MD, Thomas Lenarz MD, Gerard O’Donoghue FRCS, Oliver Adunka MD, Allison Biever AuD, Robert Briggs FRACS,8 Matthew L Carlson MD, Pu Dai, MD, Colin Driscoll MD, Howard W Francis MD, Bruce Gantz MD, Richard K Gurgel MD, Marlan Hansen MD, Meredith Holcomb AuD, Eva Karltorp MD, Milind Kirtane MS ENT, Jannine Larky AuD, Emmanuel Mylanus MD, J Thomas Roland Jr MD, Shakeel R Saeed MD, Henryk Skarzynski MD, Piotr H Skarzynski MD, Mark Syms MD, Holly Teagle AuD, Paul Van de Heyning MD, Christophe Vincent MD, Hao Wu MD, Tatsuya Yamasoba MD, Terry Zwolan PhD.
The aim of the group was to use a modified Delphi method to develop a series of consensus statements regarding the use of unilateral CIs for treating bilateral severe, profound or moderate sloping to profound sensorineural hearing loss (SNHL). Brian Kaplan, Senior Vice President of Clinical Strategy & Innovation at Cochlear Unilateral Cochlear Implants for Bilateral Severe, Profound, or Moderate Sloping to Profound Sensorineural Hearing Loss: A Systematic Review and Consensus AuthorsĪn international group of clinical experts in the fields of otology, audiology and hearing science, all with extensive clinical and scientific experience of cochlear implantation, were brought together to form a Delphi panel.
0 kommentar(er)
